At UC, 70% of undergrads participate in research, creative projects or service learning. Three new programs bridge classroom ...

The strongest human data on psychedelic and cannabis co-use comes from a 2022 prospective survey study by Kuc et al.

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...

Researchers are investigating whether GLP-1 drugs could be used to treat addiction disorders, following patient reports of reduced cravings.

T-cell therapy has transformed the treatment landscape for patients with relapsed or refractory large B-cell lymphoma (LBCL), ...

For over 50 years, many cell types have been shown to internalize HDLs (high-density lipoproteins) as whole particles, either degrading or resecreting them. HDL endocytosis occurs through at least 4 ...

Zafar Chaudry, MD, has spent 40 years in healthcare IT — the last 8.5 of them at Seattle Children’s, where he serves as senior vice president, chief digital officer and chief AI and information ...

The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...